NCT03298581 - Multiple-Dose Pharmacokinetics and Potential for Adrenal Suppression Following Treatment With Halobetasol Spray in Patients With Plaque Psoriasis | Biotech Hunter

Timeline

Start Date

January 1, 2017

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions

Plaque Psoriasis

Interventions

DRUG

Halobetasol Propionate

Experimental: Treatment with topical halobetasol spray 0.05% Patients will instructed o apply halobetasol spray twice daily for 28 days and not to rub over the affected area after application of spray.